General Information
Revision date
2008-12-09
Product name
Sample Buffer; part of "illustra mRNA Purification
supplier name
GE Healthcare UK Ltd
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
Section 2
SECTION 2: Hazards identification
Physical state Liquid. Odor Odorless. Emergency overview CAUTION! MAY CAUSE RESPIRATORY TRACT, EYE AND SKIN IRRITATION. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA.
Precautionary statements
Do not breathe vapor or mist. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Wash thoroughly after handling. Routes of entry Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Eyes Moderately irritating to eyes. Skin Moderately irritating to the skin. Inhalation Moderately irritating to the respiratory system. Ingestion No known significant effects or critical hazards.
Potential chronic health
effects Contains material that may cause target organ damage, based on animal data. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which may cause damage to the following organs: skin, eyes, stomach. Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Skin Adverse symptoms may include the following: irritation redness Eyes Adverse symptoms may include the following: irritation watering redness
Medical Conditions Generally Aggravated by Exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (Section 11)